-
1
-
-
33846941593
-
Rationale for intracoronary administration of abciximab
-
Romagnoli E., Burzotta F., Trani C., Biondi-Zoccai G.G., Giannico F., and Crea F. Rationale for intracoronary administration of abciximab. J Thromb Thrombolysis 23 1 (2007) 57-63
-
(2007)
J Thromb Thrombolysis
, vol.23
, Issue.1
, pp. 57-63
-
-
Romagnoli, E.1
Burzotta, F.2
Trani, C.3
Biondi-Zoccai, G.G.4
Giannico, F.5
Crea, F.6
-
2
-
-
33748989298
-
Intracoronary administration of abciximab during percutaneous coronary interventions: should this be the routine and preferred approach?
-
Sharma S., Makkar R., and Lardizabal J. Intracoronary administration of abciximab during percutaneous coronary interventions: should this be the routine and preferred approach?. J Cardiovasc Pharmacol Ther 11 2 (2006) 136-141
-
(2006)
J Cardiovasc Pharmacol Ther
, vol.11
, Issue.2
, pp. 136-141
-
-
Sharma, S.1
Makkar, R.2
Lardizabal, J.3
-
3
-
-
2942718762
-
Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention
-
Bellandi F., Maioli M., Gallopin M., Toso A., and Dabizzi R.P. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention. Catheter Cardiovasc Interv 62 2 (2004) 186-192
-
(2004)
Catheter Cardiovasc Interv
, vol.62
, Issue.2
, pp. 186-192
-
-
Bellandi, F.1
Maioli, M.2
Gallopin, M.3
Toso, A.4
Dabizzi, R.P.5
-
4
-
-
33746985958
-
Does intracoronary abciximab improve the outcome of percutaneous coronary interventions? A randomized controlled trial
-
Galache Osuna J.G., Sanchez-Rubio J., Calvo I., Diarte J.A., Lukic A., and Placer L.J. Does intracoronary abciximab improve the outcome of percutaneous coronary interventions? A randomized controlled trial. Rev Esp Cardiol 59 6 (2006) 567-574
-
(2006)
Rev Esp Cardiol
, vol.59
, Issue.6
, pp. 567-574
-
-
Galache Osuna, J.G.1
Sanchez-Rubio, J.2
Calvo, I.3
Diarte, J.A.4
Lukic, A.5
Placer, L.J.6
-
5
-
-
0346732105
-
Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting
-
Kakkar A.K., Moustapha A., Hanley H.G., et al. Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting. Catheter Cardiovasc Interv 61 1 (2004) 31-34
-
(2004)
Catheter Cardiovasc Interv
, vol.61
, Issue.1
, pp. 31-34
-
-
Kakkar, A.K.1
Moustapha, A.2
Hanley, H.G.3
-
6
-
-
0344519722
-
Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty
-
Wohrle J., Grebe O.C., Nusser T., et al. Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty. Circulation 107 14 (2003) 1840-1843
-
(2003)
Circulation
, vol.107
, Issue.14
, pp. 1840-1843
-
-
Wohrle, J.1
Grebe, O.C.2
Nusser, T.3
-
7
-
-
33845709129
-
A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation
-
Bertrand O.F., De Larochelliere R., Rodes-Cabau J., et al. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation. Circulation 114 24 (2006) 2636-2643
-
(2006)
Circulation
, vol.114
, Issue.24
, pp. 2636-2643
-
-
Bertrand, O.F.1
De Larochelliere, R.2
Rodes-Cabau, J.3
-
8
-
-
28444439890
-
The transulnar approach for coronary intervention: a safe alternative to transradial approach in selected patients
-
Mangin L., Bertrand O.F., De La Rochelliere R., et al. The transulnar approach for coronary intervention: a safe alternative to transradial approach in selected patients. J Invasive Cardiol 17 2 (2005) 77-79
-
(2005)
J Invasive Cardiol
, vol.17
, Issue.2
, pp. 77-79
-
-
Mangin, L.1
Bertrand, O.F.2
De La Rochelliere, R.3
-
9
-
-
0035195534
-
American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee)
-
Cannon C.P., Battler A., Brindis R.G., et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol 38 7 (2001) 2114-2130
-
(2001)
J Am Coll Cardiol
, vol.38
, Issue.7
, pp. 2114-2130
-
-
Cannon, C.P.1
Battler, A.2
Brindis, R.G.3
-
10
-
-
14344270942
-
Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention
-
Collet J.P., Montalescot G., Lesty C., et al. Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention. Circulation 103 19 (2001) 2328-2331
-
(2001)
Circulation
, vol.103
, Issue.19
, pp. 2328-2331
-
-
Collet, J.P.1
Montalescot, G.2
Lesty, C.3
-
11
-
-
0035162774
-
Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis
-
Collet J.P., Montalescot G., Lesty C., et al. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis. Arterioscler Thromb Vasc Biol 21 1 (2001) 142-148
-
(2001)
Arterioscler Thromb Vasc Biol
, vol.21
, Issue.1
, pp. 142-148
-
-
Collet, J.P.1
Montalescot, G.2
Lesty, C.3
-
12
-
-
0036282508
-
An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates
-
Marciniak Jr. S.J., Mascelli M.A., Furman M.I., et al. An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates. Thromb Haemost 87 6 (2002) 1020-1025
-
(2002)
Thromb Haemost
, vol.87
, Issue.6
, pp. 1020-1025
-
-
Marciniak Jr., S.J.1
Mascelli, M.A.2
Furman, M.I.3
-
13
-
-
0033970078
-
Double vessel occlusions after balloon angioplasty treated by stenting and subsequently by abciximab infusion
-
Bertrand O.F., Meerkin D., de Guise P., Crepeau J., and Bourassa M.G. Double vessel occlusions after balloon angioplasty treated by stenting and subsequently by abciximab infusion. Can J Cardiol 16 1 (2000) 83-85
-
(2000)
Can J Cardiol
, vol.16
, Issue.1
, pp. 83-85
-
-
Bertrand, O.F.1
Meerkin, D.2
de Guise, P.3
Crepeau, J.4
Bourassa, M.G.5
-
14
-
-
27744516623
-
Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI
-
Romagnoli E., Burzotta F., Trani C., et al. Angiographic evaluation of the effect of intracoronary abciximab administration in patients undergoing urgent PCI. Int J Cardiol 105 3 (2005) 250-255
-
(2005)
Int J Cardiol
, vol.105
, Issue.3
, pp. 250-255
-
-
Romagnoli, E.1
Burzotta, F.2
Trani, C.3
-
15
-
-
33745236055
-
Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina
-
Deibele A.J., Kirtane A.J., Pinto D.S., et al. Intracoronary bolus administration of eptifibatide during percutaneous coronary stenting for non ST elevation myocardial infarction and unstable angina. J Thromb Thrombolysis 22 1 (2006) 47-50
-
(2006)
J Thromb Thrombolysis
, vol.22
, Issue.1
, pp. 47-50
-
-
Deibele, A.J.1
Kirtane, A.J.2
Pinto, D.S.3
-
16
-
-
28044461065
-
Administration of intracoronary eptifibatide during ST-elevation myocardial infarction
-
Pinto D.S., Kirtane A.J., Ruocco N.A., et al. Administration of intracoronary eptifibatide during ST-elevation myocardial infarction. Am J Cardiol 96 11 (2005) 1494-1497
-
(2005)
Am J Cardiol
, vol.96
, Issue.11
, pp. 1494-1497
-
-
Pinto, D.S.1
Kirtane, A.J.2
Ruocco, N.A.3
-
17
-
-
32644482768
-
Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial
-
Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 367 9510 (2006) 569-578
-
(2006)
Lancet
, vol.367
, Issue.9510
, pp. 569-578
-
-
-
18
-
-
29544444716
-
Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction
-
Gershlick A.H., Stephens-Lloyd A., Hughes S., et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 353 26 (2005) 2758-2768
-
(2005)
N Engl J Med
, vol.353
, Issue.26
, pp. 2758-2768
-
-
Gershlick, A.H.1
Stephens-Lloyd, A.2
Hughes, S.3
-
19
-
-
34247862358
-
Intracoronary streptokinase after primary percutaneous coronary intervention
-
Sezer M., Oflaz H., Goren T., et al. Intracoronary streptokinase after primary percutaneous coronary intervention. N Engl J Med 356 18 (2007) 1823-1834
-
(2007)
N Engl J Med
, vol.356
, Issue.18
, pp. 1823-1834
-
-
Sezer, M.1
Oflaz, H.2
Goren, T.3
|